6533b85afe1ef96bd12b9e21
RESEARCH PRODUCT
Natalizumab Discontinuation after the 24th Course: Which Is Way? The TY-STOP Study
Marinella ClericoStefania MercantiFederico PiazzaDario GnedVincenzo Brescia MorraRoberta LanzilloLuca AmatoMario QuarantelliAngelo GhezziAnna BianchiDamiano BaronciniMarco GibbinJoseph VargasGiuseppe SalemiSabrina RealmutoMaria Teresa FerroFrancesca VitettaPatrizia SolaDamiano PaolicelliMaria TrojanoLuca Durellisubject
Multiple SclerosisNatalizumab multiple sclerosisNatalizumabSettore MED/26 - NeurologiaMRiyear | journal | country | edition | language |
---|---|---|---|---|
2013-01-01 |